Search our database by keyword

Examples

Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 601 to 619 out of 619 for Epha2

<< First < Previous | Next > Last >>

0.017s

Type

Details

Score

Publication

20197042 | -

First Author:	Bocharov EV
Year:	2010
Journal:	Biophys J
Title:	Left-handed dimer of EphA2 transmembrane domain: Helix packing diversity among receptor tyrosine kinases.
Volume:	98
Issue:	5
Pages:	881-9

•

Publication

19525919 | -

First Author:	Himanen JP
Year:	2009
Journal:	EMBO Rep
Title:	Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.
Volume:	10
Issue:	7
Pages:	722-8

•

Publication

22094251 | J:178956

First Author:	Mansour MR
Year:	2011
Journal:	Cancer Cell
Title:	Discovery of a secreted tumor suppressor provides a promising therapeutic strategy for follicular lymphoma.
Volume:	20
Issue:	5
Pages:	559-61

•

Publication

19306875 | J:147984

First Author:	Takeuchi S
Year:	2009
Journal:	FEBS Lett
Title:	Beta2-chimaerin binds to EphA receptors and regulates cell migration.
Volume:	583
Issue:	8
Pages:	1237-42

•

Publication

15133129 | -

First Author:	Ellerbroek SM
Year:	2004
Journal:	Mol Biol Cell
Title:	SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis.
Volume:	15
Issue:	7
Pages:	3309-19

•

Publication

25063526 | J:218482

First Author:	Lee J
Year:	2014
Journal:	Biochim Biophys Acta
Title:	Arhgef16, a novel Elmo1 binding partner, promotes clearance of apoptotic cells via RhoG-dependent Rac1 activation.
Volume:	1843
Issue:	11
Pages:	2438-47

•

Protein Domain

IPR034263 | EphA2_rcpt_lig-bd

Type:

Domain

Description:

This entry represents the ligand-binding domain found in ephrin type-A receptor 2 (EphA2). EphA2 negatively regulates cell differentiation and has been shown to be overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression [, , ]. Class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands [, ]. Ephrin receptors (EphRs) comprise the largest subfamily of receptor tyrosine kinases (RTKs). EphRs contain a ligand binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyrosine kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling) [].

•

Protein Domain

IPR035797 | ARHGEF16/ARHGEF26_SH3

Type:

Domain

Description:

ARHGEF16, also called ephexin-4, acts as a guanine nucleotide exchange factor (GEF) for RhoG, activating it by exchanging bound GDP for free GTP. RhoG is a small GTPase that is a crucial regulator of Rac in migrating cells. ARHGEF16 interacts directly with the ephrin receptor EphA2 and mediates cell migration and invasion in breast cancer cells by activating RhoG [, ]. ARHGEF26, also called SGEF (SH3 domain-containing GEF), also activates RhoG. It is highly expressed in liver and may play a role in regulating membrane dynamics []. ARHGEF16 and ARHGEF26 contain RhoGEF (also called Dbl-homologous or DH), Pleckstrin Homology(PH), and SH3 domains. The SH3 domains of ARHGEFs play an autoinhibitory role through intramolecular interactions with a proline-rich region N-terminal to the DH domain. The SH3 domain of ARHGEF16 also binds to Elmo, and this interaction may relieve the self-inhibitory state ofARHGEF16 [].This entry represents the SH3 domains of ARHGEF16 and ARHGEF26.

•

Publication

27619642 | J:242097

First Author:	Lee H
Year:	2016
Journal:	Nat Commun
Title:	Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis.
Volume:	7

Pages:	12799

•

Publication

20154726 | J:168266

First Author:	Zhang W
Year:	2010
Journal:	Oncogene
Title:	A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.
Volume:	29
Issue:	17
Pages:	2467-76

•

Publication

26833123 | J:231631

First Author:	Youngblood VM
Year:	2016
Journal:	Cancer Res
Title:	The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Volume:	76
Issue:	7
Pages:	1825-36

•

Publication

- | J:239145

First Author:	Gagnon LH
Year:	2017
Journal:	MGI Direct Data Submission
Title:	The pinwheel mutation

•

Publication

12370823 | J:79653

First Author:	Brantley DM
Year:	2002
Journal:	Oncogene
Title:	Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
Volume:	21
Issue:	46
Pages:	7011-26

•

Publication

12134157 | J:108902

First Author:	Carter N
Year:	2002
Journal:	Nat Cell Biol
Title:	EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
Volume:	4
Issue:	8
Pages:	565-73

•

Publication

18413883 | -

First Author:	Lackmann M
Year:	2008
Journal:	Sci Signal
Title:	Eph, a protein family coming of age: more confusion, insight, or complexity?
Volume:	1
Issue:	15
Pages:	re2

•

Protein

Q3U5C8

Organism:	Mus musculus/domesticus
Length:	713
Fragment?:	false

•

Protein

D3YYY8

Organism:	Mus musculus/domesticus
Length:	869
Fragment?:	false

•

Publication

12495863 | -

First Author:	Himanen JP
Year:	2003
Journal:	Trends Neurosci
Title:	Eph signaling: a structural view.
Volume:	26
Issue:	1
Pages:	46-51

•

Protein

Q03145

Organism:	Mus musculus/domesticus
Length:	977
Fragment?:	false

•

Questions? Comments? Click here!

MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Your name:
Your email address:
Subject:
Message:	---- Current page: ---- /mousemine/keywordSearchResults.do?searchOffset=600&searchTerm=Epha2

MouseMine

Search our database by keyword

Examples

Search results 601 to 619 out of 619 for Epha2

Categories

Hits by Pathway

Hits by Category

Hits by Strain